The store will not work correctly when cookies are disabled.
3-(2-Methoxyphenyl)-4-((3-(methylthio)phenynamino)-1H-pyrrole-2,5-dione
ID: ALA4857159
PubChem CID: 164612424
Max Phase: Preclinical
Molecular Formula: C18H16N2O3S
Molecular Weight: 340.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1C1=C(Nc2cccc(SC)c2)C(=O)NC1=O
Standard InChI: InChI=1S/C18H16N2O3S/c1-23-14-9-4-3-8-13(14)15-16(18(22)20-17(15)21)19-11-6-5-7-12(10-11)24-2/h3-10H,1-2H3,(H2,19,20,21,22)
Standard InChI Key: JVTLNYITMMFMKI-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
10.5110 -20.0326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3282 -20.0326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5826 -19.2559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9196 -18.7738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2609 -19.2559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0865 -20.7309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2672 -20.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8422 -21.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2353 -22.1284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0578 -22.1444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4792 -21.4452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8078 -20.6943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6211 -20.6939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0262 -21.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8388 -21.4003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2459 -20.6953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8345 -19.9888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0233 -19.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3601 -19.0045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4836 -19.0037 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2473 -22.1081 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.0645 -22.1081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8755 -19.9939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0585 -19.9746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
15 21 1 0
21 22 1 0
7 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.40 | Molecular Weight (Monoisotopic): 340.0882 | AlogP: 2.90 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.57 | CX Basic pKa: ┄ | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.65 | Np Likeness Score: -0.58 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |